Coagulation Market Scope and Analysis Report by 2030
Coagulation Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 6.3 Billion |
Market Size by 2030 | US$ 10.85 Billion |
Global CAGR (2022 - 2030) | 7.0% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Disease Indications
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Competitive Landscape and Key Companies:
A few of the prominent players operating in the coagulation market are NORDIC BIOMARKER; ImproGen Diagnostik Kimya San. & Tic. Ltd.; Diagnostica Stago, Inc.; Siemens Healthcare Private Limited, Sysmex; Helena Biosciences; F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Transasia Bio-Medicals; and HORIBA Medical. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.